Why Is Verapamil So Hard to Find? [Explained for 2026]

If you've been to multiple pharmacies looking for verapamil and walked away empty-handed, you're not imagining things. This widely used calcium channel blocker — prescribed for high blood pressure, heart arrhythmias, angina, and cluster headaches — has seen supply disruptions that have left patients and pharmacists frustrated. Here's an honest breakdown of why verapamil can be hard to find and what's happening in 2026.

What Is Verapamil and Why Do So Many People Need It?

Verapamil is a non-dihydropyridine calcium channel blocker — one of the oldest and most well-studied heart medications available. It's FDA-approved for hypertension, chronic stable angina, vasospastic (Prinzmetal) angina, and several heart rhythm disorders including supraventricular tachycardia (SVT) and atrial fibrillation with rapid ventricular response. Off-label, it's widely used as the first-line preventive treatment for cluster headaches.

Because it treats several common, chronic conditions — hypertension affects tens of millions of Americans — the demand for verapamil is consistently high. The drug is available in immediate-release tablets (40 mg, 80 mg, 120 mg), extended-release tablets (Calan SR, Isoptin SR), and extended-release capsules (Verelan, Verelan PM). Each formulation has its own supply chain and its own vulnerability to shortages.

What Caused Past Verapamil Shortages?

Verapamil has a documented shortage history. One of the most significant disruptions came in 2015–2016, when Hospira — the sole supplier of verapamil injection — experienced supply problems due to increased demand. For patients who needed IV verapamil in the hospital setting, this was a serious patient safety concern.

On the oral side, Mylan (now Viatris) discontinued its entire line of verapamil extended-release tablets in June 2021. Mylan had been a major generic supplier, and its exit from the market reduced competition and strained supply at pharmacies that relied on its products. Although other manufacturers like Glenmark stepped in to fill the gap, transitions of this kind often cause temporary shortages at the retail level.

Why Do Drug Shortages Happen in General?

Verapamil shortages reflect a broader problem in U.S. pharmaceutical supply chains. The root causes are usually one or more of the following:

Manufacturing consolidation: A small number of manufacturers produce most generic drugs. When one exits, there are few replacements.

Raw material shortages: Most active pharmaceutical ingredients (APIs) are manufactured overseas, primarily in India and China. Supply chain disruptions affect production.

Thin profit margins: Generic drugs like verapamil are inexpensive. Low margins make it less economically attractive for manufacturers to maintain robust production capacity.

Demand spikes: Seasonal illness, an aging population, and broader prescribing patterns can quickly outpace supply.

Pharmacy-level stocking decisions: Individual pharmacies and pharmacy chains make purchasing decisions from one or two preferred wholesalers. If their wholesaler is out, the pharmacy is out — even if other suppliers have stock.

Which Verapamil Formulations Are Most Affected?

Not all forms of verapamil face the same supply risk. Here's what to know:

Immediate-release tablets (80 mg, 120 mg): Multiple manufacturers produce these; generally the easiest to find.

Extended-release tablets (Calan SR formulations): Pfizer's Calan SR is available, and Glenmark supplies generics, but specific strengths can be intermittently unavailable.

Extended-release capsules (Verelan, Verelan PM): These have fewer generic manufacturers and tend to be more expensive and harder to source consistently.

IV injection: Hospital-use only; Pfizer (Hospira) is the primary supplier and availability can fluctuate.

What Can Patients Do When Verapamil Is Out of Stock?

If your usual pharmacy doesn't have your verapamil, you have several options:

Call other local pharmacies. Availability varies widely by location and pharmacy chain. Independent pharmacies sometimes have stock when chains don't.

Ask about a different formulation. If your ER formulation is unavailable, your doctor may be able to switch you to an IR formulation temporarily, or vice versa. Never switch on your own — doses differ.

Use medfinder.

Rather than spending hours calling pharmacies yourself, medfinder does it for you. You provide your medication, dosage, and ZIP code, and medfinder calls pharmacies near you to find out which ones can fill your prescription. Results are texted to you. It saves time and stress when you're dealing with a shortage.

Talk to your doctor about alternatives. Diltiazem (another non-dihydropyridine CCB) or a beta-blocker may be appropriate for some patients if verapamil truly cannot be found. Never change heart medications without medical supervision.

Is Verapamil Currently in Shortage in 2026?

As of 2026, verapamil is not listed as an active shortage on the FDA Drug Shortages database for most oral formulations. Multiple manufacturers now supply the extended-release tablet market following Mylan's 2021 exit. However, localized shortages still occur — meaning your pharmacy may be out even when the drug is theoretically available nationally. Specific strengths (like the 120 mg ER capsule or 240 mg ER capsule) may be harder to find at any given time.

For a deeper look at the current shortage status, see our related guide: Verapamil Shortage Update: What Patients Need to Know in 2026.

The Bottom Line

Verapamil supply disruptions are real, and they stem from structural problems in generic pharmaceutical manufacturing — not anything specific about the drug itself. The best thing you can do is act quickly when you notice your supply is low, check multiple pharmacies, and use tools like medfinder to streamline the search. For step-by-step strategies, read How to Find Verapamil in Stock Near You.